Education
About Us
Working with TipRanks
Follow Us
Adagene (ADAG)
NASDAQ:ADAG
ADAG Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.64 - $3.58
Previous CloseN/A
Volume1.51K
Average Volume (3M)28.92K
Market Cap
$88.10M
Enterprise Value$60.32M
Total Cash (Recent Filing)$92.53M
Total Debt (Recent Filing)$2.56M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Mar 27, 2025EPS Estimate
-0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding44,156,982
10 Day Avg. Volume14,784
30 Day Avg. Volume28,918
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.94
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.68
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.33
Enterprise Value/Ebitda-1.67
Forecast
1Y Price Target
$8.00Price Target Upside302.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Adagene News
PremiumCompany Announcements
Adagene Reports Promising Results in Colorectal Cancer Study
PremiumCompany Announcements
Adagene Unveils Promising Data for Cancer Therapy---
Bulls Say, Bears Say
Bulls Say
Market ValuationADAG declined 33.2% compared to NBI index's drop of 0.3% in the last two trading days, which is believed to be unwarranted and creates an attractive entry point for long-term investors.
Therapeutic PotentialADG126 presented positive data from its ongoing Phase 1/2 study at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, solidifying its therapeutical potential in metastatic microsatellite stable colorectal cancer.
Bears Say
Regulatory ChallengesThere is little clarity on the regulatory development path for ADG126 given the selective patient population.
---
Ownership Overview
―
Insiders
0.02%
Mutual Funds
12.57% Other Institutional Investors
87.40% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ADAG FAQ
What was Adagene’s price range in the past 12 months?
Adagene lowest stock price was $1.64 and its highest was $3.58 in the past 12 months.
What is Adagene’s market cap?
Adagene’s market cap is $88.10M.
When is Adagene’s upcoming earnings report date?
Adagene’s upcoming earnings report date is Mar 27, 2025 which is in 15 days.
How were Adagene’s earnings last quarter?
Adagene released its earnings results on Jul 25, 2024. The company reported -$0.285 earnings per share for the quarter, beating the consensus estimate of -$0.41 by $0.125.
Is Adagene overvalued?
According to Wall Street analysts Adagene’s price is currently Undervalued.
Does Adagene pay dividends?
Adagene does not currently pay dividends.
What is Adagene’s EPS estimate?
Adagene’s EPS estimate is -0.33.
How many shares outstanding does Adagene have?
Adagene has 44,156,982 shares outstanding.
What happened to Adagene’s price movement after its last earnings report?
Adagene reported an EPS of -$0.285 in its last earnings report, beating expectations of -$0.41. Following the earnings report the stock price went down -0.395%.
Which hedge fund is a major shareholder of Adagene?
Currently, no hedge funds are holding shares in ADAG
---
Adagene Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (302.01% Upside)
$8.00 (302.01% Upside)
Crowd Wisdom
Negative
Last 7 Days ▲ 4.2%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.43%
12-Months-Change
Fundamentals
Return on Equity
-46.16%
Trailing 12-Months
Asset Growth
-25.52%
Trailing 12-Months
Company Description
Adagene
Adagene Inc is a clinical-stage immunotherapy company focused on the design and discovery of antibodies for the treatment of cancer.
---
ADAG Stock 12 Month Forecast
Average Price Target
$8.00
▲(302.01% Upside)
Technical Analysis
Best Analysts Covering ADAG
1 Year
1 Year Success Rate
7/12 ratings generated profit
1 Year Average Return
+22.93%
reiterated a buy rating last month
Copying Arthur He CFA's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +22.93% per trade.
---